文献速递哮喘

呼出气挥发性有机物用于中重度哮喘儿童哮喘控制分类:SysPharmPediA研究结果

Exhaled Volatile Organic Compounds for Asthma Control Classification in Children with Moderate to Severe Asthma: Results from the SysPharmPediA Study.
PubMed 文献 · Am J Respir Crit Care Med · 2024-01-01

本研究评估基于气相色谱-质谱的呼出气代谢物分析区分儿童哮喘控制与未控制的准确性,包含发现阶段(SysPharmPediA)和验证阶段(U-BIOPRED和PANDA)。在SysPharmPediA中,三种化合物(苯乙酮、乙苯和苯乙烯)可区分未控制与已控制哮喘,训练集和测试集的AUROCC分别为0.83(95%CI 0.65-1.00)和0.77(95%CI 0.58-0.96);这些VOCs组合在U-BIOPRED和PANDA中的AUROCC分别为0.74±0.06和0.68±0.05。呼出气代谢物分析可能有助于儿童哮喘控制分类。

要点

  • 呼出气VOCs(苯乙酮、乙苯、苯乙烯)可区分中重度哮喘儿童的控制状态。
  • 在独立队列中验证,VOCs组合的AUROCC为0.74±0.06和0.68±0.05。
  • VOCs预测未来≥2次重度急性发作的AUROCC为0.71。

核心结论

  • 呼出气代谢物分析可能实现儿童哮喘控制分类,应促进基于呼出气代谢物的即时检测在哮喘中的进一步发展。

研究设计与样本

  • 研究包含发现阶段(SysPharmPediA)和验证阶段(U-BIOPRED和PANDA),共196名儿童完成数据收集(SysPharmPediA n=100;U-BIOPRED n=49;PANDA n=47)。

主要发现

  • 在SysPharmPediA中,将人群随机分为训练集(n=51)和测试集(n=49),三种化合物(苯乙酮、乙苯和苯乙烯)可区分未控制与已控制哮喘患者。
  • 训练集和测试集的AUROCC分别为0.83(95%CI 0.65-1.00)和0.77(95%CI 0.58-0.96)。
  • 这些VOCs组合在U-BIOPRED和PANDA中的AUROCC分别为0.74±0.06和0.68±0.05。
  • 在SysPharmPediA中,预测未来两次或以上重度哮喘发作的训练集和测试集AUROCC分别为0.71(95%CI 0.51-0.91)和0.71(95%CI 0.52-0.90)。

临床怎么用

  • 呼出气VOCs分析有望作为儿童哮喘控制分类的无创生物标志物工具,但需进一步开发即时检测方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: The early identification of children with poorly controlled asthma is imperative for optimizing treatment strategies. The analysis of exhaled volatile organic compounds (VOCs) is an emerging approach to identify prognostic and diagnostic biomarkers in pediatric asthma. Objectives: To assess the accuracy of gas chromatography-mass spectrometry-based exhaled metabolite analysis to differentiate between controlled and uncontrolled pediatric asthma. Methods: This study encompassed discovery (SysPharmPediA [Systems Pharmacology Approach to Uncontrolled Paediatric Asthma]) and validation (U-BIOPRED [Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes] and PANDA [Paediatric-Asthma-Non-Invasive-Diagnostic-Approaches]) phases. First, exhaled VOCs that discriminated degrees of asthma control were identified. Subsequently, outcomes were validated in two independent cohorts. Patients were classified as controlled or uncontrolled on the basis of asthma control test scores and the number of severe attacks in the past year. In addition, the potential of VOCs to predict two or more future severe asthma attacks in SysPharmPediA was evaluated. Measurements and Main Results: Complete data were available for 196 children (SysPharmPediA, n = 100; U-BIOPRED, n = 49; PANDA, n = 47). In SysPharmPediA, after randomly splitting the population into training (n = 51) and test (n = 49) sets, three compounds (acetophenone, ethylbenzene, and styrene) distinguished between patients with uncontrolled and controlled asthma. The areas under the receiver operating characteristic curves (AUROCCs) for training and test sets were, respectively, 0.83 (95% confidence interval [CI], 0.65-1.00) and 0.77 (95% CI, 0.58-0.96). Combinations of these VOCs resulted in AUROCCs of 0.74 ± 0.06 (U-BIOPRED) and 0.68 ± 0.05 (PANDA). Attack prediction tests resulted in AUROCCs of 0.71 (95% CI, 0.51-0.91) and 0.71 (95% CI, 0.52-0.90) for the training and test sets. Conclusions: Exhaled metabolite analysis might enable asthma control classification in children. This should stimulate the further development of exhaled metabolite-based point-of-care tests in asthma.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Shahbazi Khamas S, Van Dijk Y, Abdel-Aziz MI, et al. Exhaled Volatile Organic Compounds for Asthma Control Classification in Children with Moderate to Severe Asthma: Results from the SysPharmPediA Study. Am J Respir Crit Care Med. 2024. PMID: 38648186. doi:10.1164/rccm.202312-2270OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。